RareStone Group

RareStone Group is dedicated to building the first rare disease ecosystem in China to improve the lives of patients and families impacted by rare diseases, by bringing the best-in-the-world therapeutic solutions and comprehensive and sustainable service supports. RareStone Group consists of two business subsidiaries: Citrine Medicine and Zircon Health. Citrine Medicine is a pharmaceutical company aiming to provide effective and affordable treatment solutions to rare disease patients in China. Citrine Medicine is building a comprehensive rare disease product platform through fast licensing and co-development to support and accelerate scalable commercialization.